SYDNEY, AUSTRALIA--(Marketwired - May 21, 2015) - Simavita Limited ("Simavita" or the "Company") (TSX VENTURE:SV)(ASX:SVA) is pleased to announce the results of the Special Meeting of the Company's share/CDI holders which was held at 10.00 am today (Australian Eastern time) in North Sydney, Australia.
All four resolutions that were put before the shareholders were passed on a show of hands. Details of the proxy votes received by the Company in respect of these resolutions are contained in the following table:
| Description of Resolution | For | Against | Excluded | Totals | ||||
| 1. Approval and ratification of shares | ||||||||
| Numbers of votes received | 42,898,231 | 113,224 | - | 43,011,455 | ||||
| Percentage of votes cast | 99.74 | % | 0.26 | % | N/A | 100.00 | % | |
| 2. Approval of shares to Jackham Investments Pty. Ltd. | ||||||||
| Numbers of votes received | 42,818,898 | 192,557 | - | 43,011,455 | ||||
| Percentage of votes cast | 99.55 | % | 0.45 | % | N/A | 100.00 | % | |
| 3. Approval of shares to Warren Bingham | ||||||||
| Numbers of votes received | 42,818,898 | 192,557 | - | 43,011,455 | ||||
| Percentage of votes cast | 99.55 | % | 0.45 | % | N/A | 100.00 | % | |
| 4. Confirmation of appointment of Warren Bingham to the Board of Directors | ||||||||
| Numbers of votes received | 42,849,698 | 161,757 | - | 43,011,455 | ||||
| Percentage of votes cast | 99.62 | % | 0.38 | % | N/A | 100.00 | % | |
Note: The Company currently has a total of 92,159,678 common shares on issue and 996 share/CDI holders.
"We are extremely pleased that Warren has now joined the Simavita Board and we look forward to benefitting from his experience in innovative, first-to-market, disruptive medical technology. His background in strategic planning and commercialisation will benefit Simavita as we continue to drive our global business forward," commented Simavita CEO, Philippa Lewis.
About Simavita
Simavita is a medical device company that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ platform technology which is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.
About SIM™
SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.
Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.
The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.
Contact Information:
Philippa Lewis
Chief Executive Officer
+61 2 8405 6381
Simavita Limited
Thomas Howitt
Chief Financial Officer
+61 418 351 127
www.simavita.com
Media and Investor Relations
In Australia:
Jane Lowe
IR Department
+61 411 117 774
jane.lowe@irdepartment.com.au